CLEVELAND, April 21, 2022 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the first quarter ended March 31, 2022 before market open on Thursday, May 5, 2022. Following the release, management will hold a conference call at 9:00 a.m. Eastern Time to discuss the Company’s operating highlights and financial results.
To participate in the live call, please dial 1-866-777-2509 if dialing-in from the United States, or 1-412-317-5413 if dialing-in from other locations. For direct connection to the conference call, participants are strongly encouraged to pre-register at https://dpregister.com/sreg/10165900/f25a46ad14. A live webcast of the conference call and accompanying materials may also be accessed via the Investor Relations section of the Company’s website at https://investors.soterahealth.com/events-and-presentations. A replay of the webcast will be available later in the day on May 5.
Updates can be found from time to time on recent developments in matters relevant to investors on the Investor Relations section of the Company’s website at https://investors.soterahealth.com/special-notices. For developments related to Ethylene Oxide, updates can be found at https://investors.soterahealth.com/ethylene-oxide-eo-overview.
About Sotera Health
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®.
|Sally J. Curley, IRC||Jenny Kobin|
|Curley Global IR, LLC||IR Advisory Solutions|
|Chief Marketing Officer, Sotera Health|
Source: Sotera Health Company